Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!
Oct 18, 2024
Schizophrenia and Bipolar Disorder are often challenging to differentiate due to their overlapping symptoms. Schizophrenia is primarily marked by hallucinations and delusions, leading individuals to lose touch with reality. Patients may hear voices or see things that aren’t there, creating a profound sense of detac...
Read More...
Apr 05, 2024
Fifteen years after its first FDA approval for treating schizophrenia with Fanapt (iloperidone), Vanda Pharmaceuticals has achieved another success. Fanapt is a type of antipsychotic medication that deviates from the usual and has been administered to individuals with schizophrenia for their immediate treatment fol...
Read More...
Dec 20, 2022
AbbVie Secures Fourth FDA Approval for Vraylar AbbVie has received its fourth FDA approval for Vraylar, adding major depressive disorder (MDD) adjunctive therapy to a list that includes schizophrenia and manic and depressive episodes in bipolar disorder. According to AbbVie, the approval makes Vraylar (cariprazi...
Read More...
Apr 12, 2022
FDA Approves BioXcel’s Agitation Drug Igalmi BioXcel Therapeutics has received FDA clearance for its first drug, Igalmi, as a treatment for agitation in persons with Schizophrenia or Bipolar Disorder. Igalmi (dexmedetomidine) is the first drug approved for this application that comes in the form of a tablet that...
Read More...
Dec 01, 2021
Mental health services in the new technology-driven world offer so many options. Many of these options are accessible via intuitive apps that are designed to streamline the mental health journey and take most of the guesswork out of finding the expert attention. Most of these apps allow to access the features at an...
Read More...
Mar 31, 2021
Depression is a global health burden and continues to increase with each passing day. As per the WHO, globally, more than 264 million people of all ages suffer from depression. It is one of the leading causes of disability as measured by Years Lived with Disability (YLDs) and the fourth leading contributor to disea...
Read More...
Dec 28, 2020
Characterized by debilitating episodes of depression and mood elevation (mania or hypomania), Bipolar depression is an under-recognized and unappreciated phase of bipolar disorder. Since most patients exhibit depression, Bipolar depression gets misdiagnosed with other mental disorders easily. Thus, it is associated...
Read More...
Dec 16, 2019
Bipolar Disorder is characterized by frequent-shifts in the mood and is a manic-depressive disorder hampering the routine life of an individual. According to the American Psychiatric Association, there are four major types of bipolar disorder: Bipolar I disorder, Bipolar II disorder, Cyclothymic disorder, and Bipol...
Read More...
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Transforming Multiple Myeloma Treatment: The Promise of Novel Drug Classes
Jul 24, 2024
Newsletter/Whitepaper